Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR.
Chalabianloo F, Fadnes LT, Assmus J, Mordal J, Solli KK, Dale KS, Andersen CD, Zavenova S, Rønning BH, Blomkvist AW, Ryssdal M, Butt WSJ, Marciuch A, Ørmen AG, Ohldieck C, Løberg EM, Johansson KA; BMX-BAR and NORCATS study group. Chalabianloo F, et al. Among authors: loberg em. Trials. 2025 Jan 2;26(1):2. doi: 10.1186/s13063-024-08692-8. Trials. 2025. PMID: 39748420 Free PMC article.
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Løberg EM, Fadnes LT, Johansson KA; INTRO-HCV Study Group. Aas CF, et al. Among authors: loberg em. Subst Abuse Treat Prev Policy. 2020 Sep 3;15(1):68. doi: 10.1186/s13011-020-00309-y. Subst Abuse Treat Prev Policy. 2020. PMID: 32883319 Free PMC article.
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020.
Vold JH, Gjestad R, Aas CF, Chalabianloo F, Skurtveit S, Løberg EM, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Vold JH, et al. Among authors: loberg em. Subst Abuse Treat Prev Policy. 2020 Dec 14;15(1):93. doi: 10.1186/s13011-020-00334-x. Subst Abuse Treat Prev Policy. 2020. PMID: 33317568 Free PMC article.
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway.
Chalabianloo F, Fadnes LT, Høiseth G, Ohldieck C, Vold JH, Aas C, Løberg EM, Johansson KA, Bramness JG. Chalabianloo F, et al. Among authors: loberg em. Subst Abuse Treat Prev Policy. 2021 May 3;16(1):39. doi: 10.1186/s13011-021-00367-w. Subst Abuse Treat Prev Policy. 2021. PMID: 33941217 Free PMC article.
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold JH, Halmøy A, Chalabianloo F, Pierron MC, Løberg EM, Johansson KA, Fadnes LT. Vold JH, et al. Among authors: loberg em. BMC Psychiatry. 2023 Jun 29;23(1):479. doi: 10.1186/s12888-023-04980-w. BMC Psychiatry. 2023. PMID: 37386438 Free PMC article.
Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
Helle S, Ringen PA, Melle I, Larsen TK, Gjestad R, Johnsen E, Lagerberg TV, Andreassen OA, Kroken RA, Joa I, Ten Velden Hegelstad W, Løberg EM. Helle S, et al. Among authors: loberg em. Schizophr Res. 2016 Jan;170(1):217-21. doi: 10.1016/j.schres.2015.11.027. Epub 2015 Dec 9. Schizophr Res. 2016. PMID: 26682958 Free article.
194 results